Monitoring asthma in children.
Pijnenburg MW., Baraldi E., Brand PLP., Carlsen K-H., Eber E., Frischer T., Hedlin G., Kulkarni N., Lex C., Mäkelä MJ., Mantzouranis E., Moeller A., Pavord I., Piacentini G., Price D., Rottier BL., Saglani S., Sly PD., Szefler SJ., Tonia T., Turner S., Wooler E., Lødrup Carlsen KC.
The goal of asthma treatment is to obtain clinical control and reduce future risks to the patient. To reach this goal in children with asthma, ongoing monitoring is essential. While all components of asthma, such as symptoms, lung function, bronchial hyperresponsiveness and inflammation, may exist in various combinations in different individuals, to date there is limited evidence on how to integrate these for optimal monitoring of children with asthma. The aims of this ERS Task Force were to describe the current practise and give an overview of the best available evidence on how to monitor children with asthma. 22 clinical and research experts reviewed the literature. A modified Delphi method and four Task Force meetings were used to reach a consensus. This statement summarises the literature on monitoring children with asthma. Available tools for monitoring children with asthma, such as clinical tools, lung function, bronchial responsiveness and inflammatory markers, are described as are the ways in which they may be used in children with asthma. Management-related issues, comorbidities and environmental factors are summarised. Despite considerable interest in monitoring asthma in children, for many aspects of monitoring asthma in children there is a substantial lack of evidence.